Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €32.05 EUR
Change Today +0.115 / 0.36%
Volume 0.0
NPWA On Other Exchanges
Symbol
Exchange
London
New York
OTC US
Frankfurt
As of 2:00 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

smith & nephew plc -spon adr (NPWA) Snapshot

Open
€32.05
Previous Close
€31.93
Day High
€32.05
Day Low
€32.05
52 Week High
03/2/15 - €32.94
52 Week Low
10/17/14 - €22.93
Market Cap
14.3B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
447.2M
EX-Date
04/15/15
P/E TM
--
Dividend
€0.77
Dividend Yield
1.64%
Current Stock Chart for SMITH & NEPHEW PLC -SPON ADR (NPWA)

Related News

No related news articles were found.

smith & nephew plc -spon adr (NPWA) Related Businessweek News

No Related Businessweek News Found

smith & nephew plc -spon adr (NPWA) Details

Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the advanced surgical devices and advanced wound management sectors worldwide. The company’s Advanced Surgical Devices segment offers orthopedic reconstruction products, including hip and knee implants, as well as ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. It also provides trauma and extremities products consisting of internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints. In addition, this segment offers arthroscopy enabling technologies for healthcare providers, such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources and monitors to assist with visualization inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue; and gynecological instrumentation devices. The company’s Advanced Wound Management segment offers a range of products for the treatment of acute and chronic wounds, including leg, diabetic and pressure ulcers, burns, and post-operative wounds. This segment also provides traditional and single-use negative pressure wound therapy and hydrosurgery systems; and biologics and other bioactive technology products for debridement and dermal repair/regeneration. The company primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.

14,242 Employees
Last Reported Date: 03/5/15
Founded in 1856

smith & nephew plc -spon adr (NPWA) Top Compensated Officers

Chief Executive Officer, Director, Chairman o...
Total Annual Compensation: $3.2M
Chief Financial Officer, Director and Member ...
Total Annual Compensation: $1.8M
Compensation as of Fiscal Year 2014.

smith & nephew plc -spon adr (NPWA) Key Developments

Smith & Nephew plc Announces Consolidated Sales Results for the First Quarter Ended March 28, 2015; Provides Earnings Guidance for the Full Year 2015

Smith & Nephew plc announced consolidated sales results for the first quarter ended March 28, 2015. For the quarter, the company reported consolidated revenue of $1,104 million against $1,073 million, last year. The company provided earnings guidance for the full year 2015. The full year outlook for the Group remains unchanged and continues to expect to deliver higher underlying revenue growth in 2015 than in 2014 and an improvement in trading profit margin. The company expects the phasing of revenue and profit to be more pronounced in 2015 than 2014, with profitability in the second half being significantly stronger than the first.

Smith & Nephew Seeks Acquisitions

Smith & Nephew plc (LSE:SN.) is seeking acquisitions. Olivier Bohuon, Smith & Nephew's Chief Executive Officer, said "We are still working hard in trying to get nice potential acquisitions. As you said, to refresh memories, we are looking forward to acquire distributors in the emerging market."

Smith & Nephew plc Announces Final Dividend for the Year Ended 31 December 2014, Payable on 6 May 2015

Smith & Nephew plc announced a final dividend of 18.6 US cents per ordinary share in respect of the year ended 31 December 2014 will be paid on 6 May 2015 to shareholders whose names appeared on the register at the close of business on 17 April 2015. Those shareholders whose address on the Register is in the UK, and those who have validly elected to receive sterling dividends, will receive a dividend of 12.34 pence per share.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NPWA:GR €32.05 EUR +0.115

NPWA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Coloplast A/S kr526.00 DKK +9.50
CR Bard Inc $171.95 USD -0.43
Edwards Lifesciences Corp $130.88 USD -0.94
St Jude Medical Inc $74.27 USD -0.47
Zimmer Holdings Inc $113.77 USD -0.69
View Industry Companies
 

Industry Analysis

NPWA

Industry Average

Valuation NPWA Industry Range
Price/Earnings 31.5x
Price/Sales 3.4x
Price/Book 3.9x
Price/Cash Flow 31.4x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SMITH & NEPHEW PLC -SPON ADR, please visit www.smith-nephew.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.